Aveanna Healthcare Holdings Inc. AVAH
- Market cap
- $2.7B
- P/E
- 9.5×
Follow AVAH
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 5.89 | 0.67 | 0.70 | 2.00 | 3.67 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | 13.00 | 7.53 | 3.00 | 6.19 | 10.32 |
High Price
|
|||
| — | — | — | — | 42,000 | 33,000 | 3,700 | 33,500 | 33,500 | 35,500 |
Employees
|
|||
| — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | 1,254 | 1,384 | 1,495 | 1,679 | 1,788 | 1,895 | 2,025 | 2,433 |
Revenue
|
|||
| — | — | 30.46% | 30.29% | 30.40% | 32.31% | 30.95% | 31.42% | 31.39% | 33.31% |
Gross Margin
|
|||
| — | — | (50) | (75) | (52) | (114) | (664) | (139) | 5 | 107 |
EBT
|
|||
| — | — | (3.99%) | (5.42%) | (3.46%) | (6.77%) | (37.13%) | (7.33%) | 0.25% | 4.40% |
EBT Margin
|
|||
| — | 0 | (47) | (77) | (57) | (117) | (662) | (135) | (11) | 225 |
Net Income
|
|||
| — | — | 12 | 34 | 113 | 162 | 722 | 140 | 37 | 34 |
Depreciation
|
|||
| — | — | 6.74 | 10.11 | 10.61 | 9.84 | 9.63 | 9.98 | 10.50 | 11.96 |
Revenue/Sh
|
|||
| — | — | (0.25) | (0.56) | (0.40) | (0.69) | (3.57) | (0.71) | (0.06) | 1.11 |
Earnings/Sh
|
|||
| — | — | 0.12 | (0.06) | 0.83 | (0.07) | (0.26) | 0.12 | 0.17 | 0.62 |
Cash Flow/Sh
|
|||
| — | — | 0.00 | (0.12) | (0.11) | (0.09) | (0.06) | (0.03) | (0.03) | (0.04) |
Capex/Sh
|
|||
| — | — | 0.12 | (0.19) | 0.72 | (0.16) | (0.33) | 0.09 | 0.14 | 0.58 |
Free CF/Sh
|
|||
| — | — | 1.85 | 0.00 | 1.88 | 3.73 | (0.03) | (0.68) | (0.64) | 0.96 |
Book Value/Sh
|
|||
| — | — | 186 | 137 | 141 | 171 | 186 | 190 | 193 | 204 |
Shares
|
|||
| — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.56 |
PE Ratio
|
|||
| — | — | 1.10 | 1.10 | 1.10 | 0.75 | 0.07 | 0.28 | 0.44 | 0.68 |
PS Ratio
|
|||
| — | — | 6.28 | 6.28 | 6.28 | 1.99 | 0.00 | 0.00 | 0.00 | 8.55 |
PB Ratio
|
|||
| — | — | 1.81 | 1.81 | 1.81 | 1.54 | 0.86 | 1.01 | 1.11 | 1.21 |
EV/Sales
|
|||
| — | — | 100.12 | 100.12 | 100.12 | (94.77) | (25.54) | 116.02 | 85.37 | 24.78 |
EV/FCF
|
|||
| — | — | 22 | (9) | 117 | (11) | (48) | 23 | 33 | 126 |
Op' Cash Flow
|
|||
| — | — | (20) | (17) | (15) | (16) | (12) | (6) | (6) | (7) |
Capex
|
|||
| — | — | 22 | (25) | 101 | (27) | (60) | 17 | 26 | 118 |
FCF
|
|||
| — | — | 17 | 17 | 80 | (66) | (57) | (40) | (9) | 136 |
Working Cap'
|
|||
| — | — | 952 | 1,083 | 1,173 | 1,355 | 1,430 | 1,441 | 1,450 | 1,465 |
Total Debt
|
|||
| — | — | 944 | 1,080 | 1,036 | 1,325 | 1,411 | 1,397 | 1,365 | 1,272 |
Net Debt
|
|||
| — | — | 345 | 0 | 265 | 636 | (6) | (130) | (124) | 194 |
Sh' Equity
|
|||
| — | — | (6.06%) | (9.87%) | (6.19%) | (5.60%) | (32.72%) | (8.09%) | (0.67%) | 12.24% |
ROA
|
|||
| — | — | 0.00% | 2.25% | (0.17%) | (1.15%) | (28.58%) | 0.40% | 7.04% | 10.93% |
ROIC
|
|||
| — | — | (15.28%) | (24.88%) | (21.33%) | (25.99%) | (210.33%) | 198.00% | 8.64% | 634.70% |
ROE
|
|||
Aveanna Healthcare Holdings Inc. peers in Medical Care Facilities
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| GRDN Guardian Pharmacy Services, Inc. | $2.7B | 39.2× | Compare |
| BKD Brookdale Senior Living Inc. | $2.6B | 0.0× | Compare |
| ACHC Acadia Healthcare Company, Inc. | $2.6B | 0.0× | Compare |
| ADUS Addus HomeCare Corporation | $2.1B | 19.9× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| OPCH Option Care Health, Inc. | $3.4B | 17.3× | Compare |
| NHC National HealthCare Corporation | $3.5B | 25.2× | Compare |
| MD Pediatrix Medical Group, Inc. | $2.1B | 12.6× | Compare |
| SGRY Surgery Partners, Inc. | $1.9B | 0.0× | Compare |
Aveanna Healthcare Holdings Inc. (AVAH) key facts
- Aveanna Healthcare Holdings Inc. (AVAH) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
- Aveanna Healthcare Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 20.2% from fiscal 2024.
- Net income was $225.0 million, or $1.11 per share (basic), a net margin of 9.25%.
- As of September 25, 2026, AVAH traded at $12.41, a market capitalization of $2.7 billion.
- At that price the stock trades at 9.5× trailing-twelve-month earnings and 1.0× sales.
- Return on equity was 634.7% and debt-to-equity 5.09.
Aveanna Healthcare Holdings Inc. (AVAH) Latest News
4 Sep
Aveanna Healthcare Holdings (AVAH) stock fair value rises after Q2 results and analyst revisions. Q2 results and analyst revisions raise AVAH fair value, moderately affecting sentiment and trajectory.
28 Aug
Aveanna Healthcare Holdings Inc. (AVAH) shares hit a new all-time high, positioning the stock as an attractive option that delivers on investor expectations for growth and returns. New all-time high improves short-term market sentiment and visibility but does not alter core operations or long-term fundamentals.
26 Aug
Rising earnings estimates for Aveanna Healthcare Holdings Inc. (AVAH) raise prospects for stock gains. Rising earnings estimates may lift short-term AVAH stock sentiment without altering core operations.
24 Aug
RBC states secular tailwinds support Aveanna Healthcare Holdings Inc. growth trajectory. RBC positive note on secular tailwinds may lift AVAH sentiment without altering core trajectory.
21 Aug
Aveanna Healthcare Holdings Inc. (AVAH) has concluded a four-year rate dispute. Resolution of the prolonged rate dispute stands to materially improve Aveanna's reimbursement levels and financial trajectory.
Aveanna Healthcare Holdings Inc. (AVAH) announced new growth targets, prompting questions on whether the stock remains undervalued. New growth targets may moderately affect Aveanna's financial performance and market valuation.
20 Aug
Aveanna Healthcare Holdings Inc. (AVAH) released the transcript of its Q2 2026 earnings call covering financial results and business outlook. Earnings call details financial performance and guidance that can significantly shift investor views and AVAH stock trajectory.
14 Aug
Aveanna Healthcare Holdings Inc. (AVAH) raised growth targets in its Q2 earnings call. Raised growth targets from Q2 earnings call strengthen AVAH outlook and investor sentiment.
13 Aug
Aveanna Healthcare Holdings Inc reported strong revenue growth in Q2 2026 earnings call, highlighting improved financial performance and operational metrics. Strong Q2 2026 revenue results signal major positive shifts in financial trajectory and investor sentiment.
Aveanna Healthcare Holdings Inc. reported second quarter financial results and issued revised 2026 guidance. Quarterly results plus revised 2026 guidance directly shift earnings expectations and valuation.
Aveanna Healthcare Holdings Inc. held its Q2 2026 earnings call covering financial results and operational updates. Quarterly earnings data can shift near-term stock sentiment and valuation multiples for AVAH.
Aveanna Healthcare Holdings Inc. (AVAH) Q2 earnings call covered revenue figures, operational metrics, and management commentary on business outlook. Q2 earnings call reveals key financial metrics and guidance influencing AVAH stock performance.
Aveanna (AVAH) Q2 earnings include key metrics compared to estimates. Q2 earnings metrics versus estimates can shift AVAH stock trajectory based on deviations from expectations.
Aveanna Healthcare Holdings Inc. (AVAH) surpassed Q2 earnings and revenue estimates. Beating quarterly estimates signals stronger financial results without indicating major strategic shifts.
10 Aug
Aveanna Healthcare Holdings faces potential Q2 earnings pressure from declining PDS margins. Lower PDS margins could directly pressure Aveanna's quarterly earnings and near-term financial results.
22 Jun
Aveanna Healthcare Holdings Inc. (AVAH) shows positioning for a stock surge driven by operational strengths and favorable market conditions. Positive outlook on AVAH highlights factors that may moderately influence stock trajectory without major structural shifts.
2 Jun
Aveanna Healthcare Holdings Inc. raised its 2026 outlook after the Family First deal and projects 7%-10% growth. Family First deal directly drives raised 2026 outlook and 7%-10% growth forecast for Aveanna Healthcare.
Aveanna Healthcare Holdings Inc. completed the acquisition of Family First Homecare and updated its full year 2026 guidance. Acquisition expands operations while updated guidance directly revises financial outlook and investor expectations.
28 May
Aveanna Healthcare Holdings Inc. completed a successful debt repricing. Debt repricing lowers interest costs and improves Aveanna Healthcare Holdings Inc. financial flexibility.
22 May
Aveanna Healthcare Holdings Inc. (AVAH) earnings contain underlying issues that raise concerns about financial reporting quality and sustainability, likely pressuring investor confidence and share price. Negative earnings analysis can sway short-term sentiment and valuation without altering long-term fundamentals.
15 May
Aveanna Healthcare Holdings (AVAH) share price surged recently, prompting analysis of whether current valuation fully captures the move or still offers upside potential for investors. Stock valuation questions after a surge can shift near-term investor sentiment and trading but rarely alter core operations or long-term trajectory.
14 May
Aveanna Healthcare Holdings Inc. (AVAH) reported strong revenue growth in Q1 2026 earnings call highlights. Strong revenue growth in Q1 2026 indicates significant positive impact on AVAH's financial trajectory and investor sentiment.
Aveanna Healthcare Holdings Inc. (AVAH) released Q1 earnings call highlights, covering financial results, revenue growth, adjusted EBITDA, guidance updates, and strategic initiatives amid home health and hospice segment performance. Q1 earnings highlights reveal financial metrics and forward guidance that significantly shape investor expectations and stock trajectory.
Aveanna Healthcare Holdings Inc. (AVAH) shares climbed after strong quarterly results and raised full-year guidance. Strong quarterly results and higher guidance signal significant positive shift in financial trajectory and investor sentiment.
Aveanna Healthcare Holdings Inc. (AVAH) Q1 earnings compared to analyst estimates, with analysis of key metrics. Q1 earnings versus estimates directly affect financial results, stock price volatility, and investor outlook.
Aveanna Healthcare Holdings Inc. (AVAH) exceeded Q1 earnings and revenue estimates. Beating Q1 earnings and revenue estimates signals strong financial performance, likely boosting investor sentiment and stock price.
Aveanna Healthcare Holdings Inc. announced first quarter financial results and revised its 2026 guidance. Q1 results and revised 2026 guidance represent major updates to financial performance and long-term outlook, likely shifting investor sentiment and trajectory.
17 Apr
Wall Street analysts forecast 43.07% upside potential remaining for Aveanna Healthcare Holdings Inc. (AVAH) stock. Analyst consensus projecting 43.07% upside for AVAH signals moderate positive impact on investor sentiment and market performance.
2 Apr
Barclays adjusted its outlook for Aveanna Healthcare Holdings Inc. (AVAH) following Q4 results while maintaining an Overweight rating. Barclays' post-Q4 outlook adjustment with retained Overweight rating signals moderate positive influence on investor sentiment and financial performance expectations.
27 Mar
Aveanna Healthcare Holdings (AVAH) reported promising earnings that may rest on soft foundations. Promising earnings face scrutiny over weak underlying foundations, moderately impacting financial perception and market sentiment.